Figure 5 Bioresorbable vascular scaffold apposition and strut coverage

Slides:

Advertisements

Similar presentations

Nat. Rev. Cardiol. doi: /nrcardio

Advertisements

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Comparison of prevalence of uncovered struts between ZES and EES groups. Comparison of prevalence of uncovered struts between ZES and EES groups. Scatter plot.

Nat. Rev. Cardiol. doi: /nrcardio

Figure 10 Assessment of myocardial fibrosis

Figure 5 BMI and cardiorespiratory fitness levels

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Pharmacodynamic comparison of crushed versus integral

Figure 4 BMI and mortality in patients with heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Mechanisms of metastatic growth in the heart

Figure 2 Pathological specimens showing the most common reasons for bioprosthetic valve failure Figure 2 | Pathological specimens showing the most common.

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Global rates of sodium, fruit, and vegetable intake

Figure 1 Anatomy of the femoral artery

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Management of acute coronary syndrome with intact fibrous cap

Figure 2 Three-year survival rates on the basis of body composition

Figure 3 3D printing of aortic and mitral valves

Nat. Rev. Cardiol. doi: /nrcardio

Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)

Figure 8 4D magnetic resonance imaging patterns

Figure 4 Valve-in-valve implantations in degenerated surgical valves

Figure 6 Pharmacodynamic profile of switching between clopidogrel and ticagrelor therapy: results from the RESPOND study Figure 6| Pharmacodynamic profile.

Figure 2 Imaging of atherosclerotic plaque burden

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Ultrasound-guided femoral artery access

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Health-care system today

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Cardiovascular risk and disease across the life-course

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 The depolarization theory of Brugada syndrome

Figure 1 Decision tree integrating the assessment,

Figure 1 Types of surgical and transcatheter aortic valves

Figure 1 Cardiovascular 3D printing workflow

Figure 3 Neural crest cell migration

Figure 2 Global cost of HF per capita in 2012

Ana Rita Ramalho et al. JCIN 2017;10:

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Milestones in coronary angioplasty

Figure 3 Challenges for big data applications in cardiovascular care

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 12 Cardiac gossypiboma

Figure 6 The neurogenic components of angina

Any and definite stent thrombosis (ST) and in-device late lumen loss (LLL) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES) in.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Impaired mitochondrial capacity and function in heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)

Nat. Rev. Cardiol. doi: /nrcardio

Konstantina P. Bouki, Dionissios N. Chatzopoulos, Mihail G

Figure 3 Imaging of adverse plaque characteristics

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Photographs showing optical coherence tomography (OCT) images after deployment of the new Low-profile Visualized Intraluminal Support device (LVIS Blue)

Nat. Rev. Cardiol. doi: /nrcardio

Angiographic and corresponding optical coherence tomography (OCT) images. Angiographic and corresponding optical coherence tomography (OCT) images. (A)

A) Conventional pulmonary angiogram, with b) and c) corresponding optical coherence tomography images from a patient with chronic thromboembolic pulmonary.

Nat. Rev. Cardiol. doi: /nrcardio

Presentation transcript:

Figure 5 Bioresorbable vascular scaffold apposition and strut coverage Reprinted from Gomez-Lara, J. et al. Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography. JACC Cardiovasc. Interv. 4 (9), 992–1001 © (2011), with permission from Elsevier Ong, D. S. & Jang I. ‑K. (2015) Causes, assessment, and treatment of stent thrombosis—intravascular imaging insights Nat. Rev. Cardiol. doi:10.1038/nrcardio.2015.32